This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Cote D'azur. Active years: 2024.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 25 Years Active: 2024
Title: Gian Marco De Donatis: Innovator in Pharmaceutical Chemistry
Introduction
Gian Marco De Donatis is a notable inventor based in Nice, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Gian Marco De Donatis holds a patent for "Substituted halo-quinoline derivatives, method of preparation and applications thereof." This invention relates to a compound of general formula (I), where R is OCHCHOCH or OCH, R' is H or OH, and R is Cl, F, Br, or I. The patent specifies that when R is OCHCHOCH, then R' is H, and when R is OCH, R' is OH. The invention also encompasses pharmaceutically acceptable salts, optical isomers, tautomers, solvates, or isotopic variations of these compounds. These compounds are particularly relevant for the treatment of various solid tumor cancers, including melanoma, colon, lung, pancreas, kidney, Merkel carcinoma, squamous cell carcinoma, prostate, breast, and bladder. Additionally, the invention includes a pharmaceutical composition comprising these compounds.
Career Highlights
Throughout his career, Gian Marco De Donatis has worked with prestigious organizations such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Gian Marco has collaborated with notable colleagues, including Thierry Passeron and Rachid Benhida. Their joint efforts have furthered the understanding and development of innovative solutions in pharmaceutical chemistry.
Conclusion
Gian Marco De Donatis is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact cancer treatment significantly. His patent on substituted halo-quinoline derivatives exemplifies his commitment to advancing medical science and improving patient outcomes.